Comparison between vildagliptin and metformin to sustain reductions in HbA1cover 1 year in drug-naïve patients with Type 2 diabetes-Reference-Cited by-同舟云学术

Comparison between vildagliptin and metformin to sustain reductions in HbA1cover 1 year in drug-naïve patients with Type 2 diabetes

Published:2007-05-17 Issue:9 Volume:24 Page:955-961
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Schweizer A.,Couturier A.,Foley J. E.,Dejager S.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2007.02191.x/fullpdf

Reference27 articles.

1. Ahrén B Landin-Olsson M Jansson P-A Svenson M Holmes D Schweizer A. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels and reduces glucagon levels in type 2 diabetes. J Clin Endocrinol Metab 2004 89 2078 2084

2. Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes;Mari;J Clin Endocrinol Metab,2005

3. Holst JJ Deacon CF. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 2005 48 612 615

4. Pratley R Galbreath E. Twelve-week monotherapy with the DPP-4 inhibitor, LAF237, improves glycemic control in patients with type 2 diabetes (T2DM). Diabetes 2004 53 A83

5. Ristic S Byiers S Foley J Holmes D. Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose-response. Diabetes Obes Metab 2005 7 692 698

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population;Frontiers in Endocrinology;2022-08-17

2. Contrasting Three Non-hypoglycemic Antidiabetic Drug Effects on Glycemic Control in Newly Diagnosed Type II Diabetes Mellitus: An Experimental Study;Open Access Macedonian Journal of Medical Sciences;2022-02-17

3. Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications;The Journal of Clinical Endocrinology & Metabolism;2021-12-09

4. Efficacy of Bilberry and Grape Seed Extract Supplement Interventions to Improve Glucose and Cholesterol Metabolism and Blood Pressure in Different Populations—A Systematic Review of the Literature;Nutrients;2021-05-17

5. Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy;Meditsinskiy sovet = Medical Council;2021-01-17